Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus

Treatment strategies for esophageal adenocarcinoma patients continue to advance with the generation of more data from clinical trials that are permitting us to refine the use of immunotherapy in combination with other treatment modalities. While the frontline therapy for metastatic esophageal adenoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Malla, Midhun, Fuqua, Jacob, Mukherjee, Sarbajit, Goldberg, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Upper Gastrointestinal Cancers (JD Berlin, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589739/
https://www.ncbi.nlm.nih.gov/pubmed/36272049
http://dx.doi.org/10.1007/s11864-022-01029-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589739/
https://www.ncbi.nlm.nih.gov/pubmed/36272049
http://dx.doi.org/10.1007/s11864-022-01029-0

Ejemplares similares